{&quot;resourceType&quot;:&quot;ValueSet&quot;,&quot;id&quot;:&quot;botswana-amr-interpretation&quot;,&quot;text&quot;:{&quot;status&quot;:&quot;extensions&quot;,&quot;div&quot;:&quot;&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;&lt;p class=\&quot;res-header-id\&quot;&gt;&lt;b&gt;Generated Narrative: ValueSet botswana-amr-interpretation&lt;/b&gt;&lt;/p&gt;&lt;a name=\&quot;botswana-amr-interpretation\&quot;&gt; &lt;/a&gt;&lt;a name=\&quot;hcbotswana-amr-interpretation\&quot;&gt; &lt;/a&gt;&lt;ul&gt;&lt;li&gt;Include these codes as defined in &lt;a href=\&quot;http://terminology.hl7.org/6.4.0/CodeSystem-v3-ObservationInterpretation.html\&quot;&gt;&lt;code&gt;http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation&lt;/code&gt;&lt;/a&gt;&lt;table class=\&quot;none\&quot;&gt;&lt;tr&gt;&lt;td style=\&quot;white-space:nowrap\&quot;&gt;&lt;b&gt;Code&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Display&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Definition&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;a href=\&quot;http://terminology.hl7.org/6.4.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-S\&quot;&gt;S&lt;/a&gt;&lt;/td&gt;&lt;td&gt;Susceptible&lt;/td&gt;&lt;td&gt;Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2&lt;br/&gt;&lt;br/&gt;\\[Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.\\]&lt;br/&gt;&lt;br/&gt;\\[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;a href=\&quot;http://terminology.hl7.org/6.4.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-I\&quot;&gt;I&lt;/a&gt;&lt;/td&gt;&lt;td&gt;Intermediate&lt;/td&gt;&lt;td&gt;Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2&lt;br/&gt;&lt;br/&gt;\\[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.\\]&lt;br/&gt;&lt;br/&gt;\\[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.\\]&lt;br/&gt;&lt;br/&gt;\\[Note 3: This class also indicates a &amp;quot;buffer zone,&amp;quot; to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.\\]&lt;br/&gt;&lt;br/&gt;\\[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\]&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;a href=\&quot;http://terminology.hl7.org/6.4.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-R\&quot;&gt;R&lt;/a&gt;&lt;/td&gt;&lt;td&gt;Resistant&lt;/td&gt;&lt;td&gt;Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2&lt;br/&gt;&lt;br/&gt;\\[Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.\\]&lt;br/&gt;&lt;br/&gt;\\[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&quot;},&quot;url&quot;:&quot;http://example.org/fhir/ImplementationGuide/bw-amr-ig/ValueSet/botswana-amr-interpretation&quot;,&quot;version&quot;:&quot;0.1.0&quot;,&quot;name&quot;:&quot;BotswanaAMRInterpretation&quot;,&quot;title&quot;:&quot;Botswana AMR Interpretation&quot;,&quot;status&quot;:&quot;draft&quot;,&quot;date&quot;:&quot;2025-06-17T18:14:37-04:00&quot;,&quot;publisher&quot;:&quot;University of Botswana Partnership&quot;,&quot;contact&quot;:[{&quot;name&quot;:&quot;University of Botswana Partnership&quot;,&quot;telecom&quot;:[{&quot;system&quot;:&quot;url&quot;,&quot;value&quot;:&quot;https://github.com/Dokotela/bw-amr-ig&quot;}]}],&quot;description&quot;:&quot;Only Susceptible, Intermediate, or Resistant&quot;,&quot;compose&quot;:{&quot;include&quot;:[{&quot;system&quot;:&quot;http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation&quot;,&quot;concept&quot;:[{&quot;code&quot;:&quot;S&quot;,&quot;display&quot;:&quot;Susceptible&quot;},{&quot;code&quot;:&quot;I&quot;,&quot;display&quot;:&quot;Intermediate&quot;},{&quot;code&quot;:&quot;R&quot;,&quot;display&quot;:&quot;Resistant&quot;}]}]}}